Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

Jennifer L. Harcourt(Centers for Disease Control and Prevention), Natalie J. Thornburg(Oak Ridge Associated Universities)

Emerging infectious diseases

March 11, 2020

10.3201/eid2606.200516

Cited by 628

Related Papers

The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

|The Lancet|2017|423

Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient

|bioRxiv (Cold Spring Harbor Laboratory)|2020|155